Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neumora Therapeutics, Inc. | Director | Common Stock | 7.82M | $93.7M | $11.98 | Feb 14, 2024 | Direct |
Jazz Pharmaceuticals plc | Director | Ordinary Shares | 8.29K | $988K | $119.13 | Aug 5, 2021 | Direct |
Neumora Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 343K | Feb 14, 2024 | Direct | ||
Unity Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 21, 2024 | Direct | ||
EQRx, Inc. | Director | Common Stock | 0 | $2.21 | Nov 9, 2023 | Direct | |
EQRx, Inc. | Director | Earn-out Shares | 0 | Nov 9, 2023 | Direct | ||
EQRx, Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
UBX | Unity Biotechnology, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
NMRA | Neumora Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 16, 2024 | Director |
EQRX | EQRx, Inc. | Nov 9, 2023 | 3 | $0 | 4 | Nov 9, 2023 | Director |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Director |
UBX | Unity Biotechnology, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
EQRX | EQRx, Inc. | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
EQRX | EQRx, Inc. | Sep 30, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
UBX | Unity Biotechnology, Inc. | Jun 24, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
EQRX | EQRx, Inc. | Dec 17, 2021 | 2 | $0 | 4 | Dec 21, 2021 | Director |
EQRX | EQRx, Inc. | Dec 17, 2021 | 0 | $0 | 3 | Dec 20, 2021 | Director |
JAZZ | Jazz Pharmaceuticals plc | Aug 5, 2021 | 1 | -$223K | 4 | Aug 9, 2021 | Director |
UBX | Unity Biotechnology, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |